- Home
- VRNA vs ASTH Comparison
VRNA vs ASTH Comparison
Compare VRNA & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNA
- ASTH
- Stock Information
- Founded
- VRNA 2005
- ASTH 1994
- Country
- VRNA United Kingdom
- ASTH United States
- Employees
- VRNA N/A
- ASTH N/A
- Industry
- VRNA Biotechnology: Pharmaceutical Preparations
- ASTH Professional Services
- Sector
- VRNA Health Care
- ASTH Consumer Discretionary
- Exchange
- VRNA Nasdaq
- ASTH Nasdaq
- Market Cap
- VRNA 2.2B
- ASTH 2.5B
- IPO Year
- VRNA 2017
- ASTH N/A
- Fundamental
- Price
- VRNA $35.66
- ASTH $40.81
- Analyst Decision
- VRNA Strong Buy
- ASTH Strong Buy
- Analyst Count
- VRNA 6
- ASTH 6
- Target Price
- VRNA $43.83
- ASTH $68.20
- AVG Volume (30 Days)
- VRNA 1.1M
- ASTH 310.0K
- Earning Date
- VRNA 11-04-2024
- ASTH 11-07-2024
- Dividend Yield
- VRNA N/A
- ASTH N/A
- EPS Growth
- VRNA N/A
- ASTH 34.94
- EPS
- VRNA N/A
- ASTH 1.30
- Revenue
- VRNA $5,624,000.00
- ASTH $1,722,367,000.00
- Revenue This Year
- VRNA N/A
- ASTH $37.96
- Revenue Next Year
- VRNA $554.09
- ASTH $24.20
- P/E Ratio
- VRNA N/A
- ASTH $31.36
- Revenue Growth
- VRNA 1127.95
- ASTH 29.71
- 52 Week Low
- VRNA $11.39
- ASTH $32.04
- 52 Week High
- VRNA $40.13
- ASTH $63.20
- Technical
- Relative Strength Index (RSI)
- VRNA 51.76
- ASTH 24.75
- Support Level
- VRNA $36.49
- ASTH $53.69
- Resistance Level
- VRNA $40.13
- ASTH $60.99
- Average True Range (ATR)
- VRNA 2.01
- ASTH 2.90
- MACD
- VRNA -0.30
- ASTH -1.76
- Stochastic Oscillator
- VRNA 47.60
- ASTH 6.44
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
About ASTH Astrana Health Inc. Common Stock
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.